Author

Mark D. Minden

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Cheryl H. ArrowsmithiD· 1 shared Dalia Barsyte-LovejoyiD· 1 shared Ella C. Adamson· 1 shared Fengling Li· 1 shared Genna M. Luciani· 1 shared Magdalena M. SzewczykiD· 1 shared Mona A. AlqazzaziD· 1 shared Raquel A.C. MachadoiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Cheryl H. ArrowsmithORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivNov 20, 2023

Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations

Mona A. Alqazzaz, Genna M. Luciani, Victoria Vu…·Dalia Barsyte-Lovejoy

This study identifies epigenetic vulnerabilities in AML and MDS/MPN with EZH2 mutations, showing increased sensitivity to EZH2 and EED inhibitors and upregulation of cell death pathways.

DOI 10.1016/j.exphem.2023.11.009

humanChIP-seq

𝕏 PostBluesky